Pathogenesis and Treatment of Chronic Inflammatory Conditions


Support Future Events

Help keep these events free to the public.

About the Event

There are striking similarities between chronic Lyme disease, long COVID, ME/CFS, and other chronic inflammatory conditions.

Dr. Bruce Patterson and his team have developed a novel protocol to treat these chronic sufferers and his approach has been found to have excellent results in nearly 500 patients who were treated with the same therapy.

This event will cover a variety of topics including the research Dr. Patterson has conducted into these chronic conditions, an explanation of his treatment protocol, and how your doctor can learn to adapt it in their own practice.

*Disclaimer, all opinions shared during this presentation are those of the presenters and not Project Lyme. This discussion is for educational purposes only, and you should always confer with your doctor before beginning any new treatment protocol. 

About the Guests

Dr. Bruce Patterson, MD received his undergraduate training in molecular biology from the University of Michigan in Ann Arbor. He then received his MD at Northwestern University Feinberg School of Medicine followed by a residency in pathology. During the early stages of the AIDS epidemic, Dr. Patterson began investigating cellular reservoirs of HIV-1 using molecular and in situ cell-based technology patented in his laboratory and used today around the world. Dr. Patterson determined that enough HIV virus was present in infected individuals to account for the massive destruction of the immune system. This paradigm-altering work was published in Science in 1993 and featured in Scientific American, Rolling Stone, and on the Discovery Channel. Dr. Patterson has authored over 150 manuscripts and book chapters focusing on single-cell biology and diagnostics. Dr. Patterson was formerly Associate Professor of Pathology and Infectious Diseases and Director of Virology at Stanford University. He currently serves as CEO and founder of IncellDx Inc., a growth-stage company that has translated his research discoveries into state-of-the-art single-cell diagnostics in Cancer, Immuno-Oncology, and Infectious Diseases, especially COVID.

About the Sponsors

Project Lyme

Our mission is to eradicate the epidemic of tick-borne diseases through awareness and education, support of cutting-edge science, and advocacy for solutions to end the suffering. As a national Lyme disease non-profit, we aim to impact patients’ lives through our work.